NAPIZOLE 40MG 14CAP

-Gastroesophageal reflux disease: Initial therapy: Mild/intermittent disease (<2 episodes/week) and no evidence of erosive esophagitis: Oral: 10 mg once daily; can increase to 20 mg once daily after 4 to 8 weeks if necessary. Discontinue once asymptomatic for 8 weeks, Severe and/or frequent symptoms (≥2 episodes/week) and/or erosive esophagitis: Oral: 20 to 40 mg once daily; once symptoms are controlled, continue for at least 8 weeks.